Terminal modification is established as a minimal, sequence-preserving strategy to reprogram the organization and function of self-assembling integrin ligands to diversify the biological output of a shared bioactive sequence.
Zi-Yi Su, Yan-Ling Lin, Zhu Zhu et al.· bioRxiv· 0 citations
A minimalist, intrinsically mitochondria-targeting noncanonical tetrapeptide, X-GNNpY, comprising one glycine, two (S)-2-amino-3-(naphthalen-1-yl)-propanoic acid residues (N, and one phosphorylated tyrosine) is reported, which selectively accumulates in tumor-cell mitochondria through enzyme-instructed self-assembly.
Zi-Yu Jia, Jian Wen, Sheng-Yi Zhang et al.· Journal of the American Chem...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.